GB1343595A - Oral contraceptive combination - Google Patents
Oral contraceptive combinationInfo
- Publication number
- GB1343595A GB1343595A GB4224272A GB4224272A GB1343595A GB 1343595 A GB1343595 A GB 1343595A GB 4224272 A GB4224272 A GB 4224272A GB 4224272 A GB4224272 A GB 4224272A GB 1343595 A GB1343595 A GB 1343595A
- Authority
- GB
- United Kingdom
- Prior art keywords
- substance
- estrogenic
- weight
- range
- unit dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940127234 oral contraceptive Drugs 0.000 title abstract 2
- 239000003539 oral contraceptive agent Substances 0.000 title abstract 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract 2
- 230000001072 progestational effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical compound OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 abstract 1
- 229940053934 norethindrone Drugs 0.000 abstract 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical group O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 abstract 1
- 230000000624 ovulatory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00228365A US3836651A (en) | 1972-02-22 | 1972-02-22 | Novel oral contraceptive combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1343595A true GB1343595A (en) | 1974-01-10 |
Family
ID=22856883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4224272A Expired GB1343595A (en) | 1972-02-22 | 1972-09-12 | Oral contraceptive combination |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3836651A (enExample) |
| AU (1) | AU463937B2 (enExample) |
| DE (1) | DE2253916A1 (enExample) |
| FR (1) | FR2172953B1 (enExample) |
| GB (1) | GB1343595A (enExample) |
| IL (1) | IL40376A0 (enExample) |
| ZA (1) | ZA726265B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2192542A (en) * | 1986-07-15 | 1988-01-20 | American Home Prod | Dosage form for pre-menopausal women |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58500802A (ja) * | 1981-05-29 | 1983-05-19 | ソロタ−ル，オリオン | フオ−クリフトにおける又はフオ−クリフトに関する改良 |
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| US5010070A (en) * | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
| US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
| US5116818A (en) * | 1987-03-10 | 1992-05-26 | Medical College Of Hampton Roads | Method and kit for contraception with GnRH-antagonist |
| WO1988007056A1 (en) * | 1987-03-10 | 1988-09-22 | Eastern Virginia Medical Authority | METHOD AND KIT FOR CONTRACEPTION WITH GnRH-ANTAGONIST AND PROGESTIN |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| DK174071B1 (da) * | 1987-09-24 | 2002-05-21 | Jencap Res Ltd | Kontraceptivt præparat i form af en pakning omfattende enhedsdoser |
| US5116865A (en) * | 1990-09-05 | 1992-05-26 | Peters Richard H | 15,16-seco-19-nor progestins |
| US5433219A (en) * | 1992-09-23 | 1995-07-18 | Spery; Nanette S. | Receptive condom assembly |
| US6214815B1 (en) | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
| US7989436B2 (en) * | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
| US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
| US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
| US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
| JP2004140323A (ja) * | 2002-08-20 | 2004-05-13 | Sharp Corp | 半導体レーザ装置およびその製造方法 |
| US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
| JP2006522833A (ja) * | 2003-04-11 | 2006-10-05 | バー・ラボラトリーズ，インコーポレイテッド | エストロゲンおよびプロゲスチンの投与法 |
-
1972
- 1972-02-22 US US00228365A patent/US3836651A/en not_active Expired - Lifetime
- 1972-09-12 GB GB4224272A patent/GB1343595A/en not_active Expired
- 1972-09-13 ZA ZA726265A patent/ZA726265B/xx unknown
- 1972-09-14 AU AU46704/72A patent/AU463937B2/en not_active Expired
- 1972-09-15 IL IL40376A patent/IL40376A0/xx unknown
- 1972-10-23 FR FR7237541A patent/FR2172953B1/fr not_active Expired
- 1972-11-03 DE DE2253916A patent/DE2253916A1/de active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2192542A (en) * | 1986-07-15 | 1988-01-20 | American Home Prod | Dosage form for pre-menopausal women |
| GB2192542B (en) * | 1986-07-15 | 1990-05-02 | American Home Prod | Combination dosage form for pre-menopausal women |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2172953B1 (enExample) | 1975-10-31 |
| FR2172953A1 (enExample) | 1973-10-05 |
| AU4670472A (en) | 1974-03-21 |
| ZA726265B (en) | 1973-06-27 |
| US3836651A (en) | 1974-09-17 |
| AU463937B2 (en) | 1975-08-07 |
| IL40376A0 (en) | 1972-11-28 |
| DE2253916A1 (de) | 1973-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1343595A (en) | Oral contraceptive combination | |
| NL300025I1 (nl) | Combinatie doseringsvorm voor vrouwen in de pre-menopauze. | |
| GB1490099A (en) | Contraceptive method and pack | |
| IL92069A0 (en) | Contraception system and method | |
| KR890700349A (ko) | 피임 및 유방암 억제용 조성물 및 이의 제조방법 | |
| RU96115196A (ru) | Состав для контрацепции | |
| GB1384214A (en) | Oral contraceptive regimens and packaged unit dosage forms thereof | |
| US3795734A (en) | Cyclic regimen of hormone administration for contraception | |
| KR920011514A (ko) | 프로게스토겐만을 함유하는 피임제 | |
| Tillander et al. | EXCRETION RATE OF METHYL MERCURY IN THE SEAL(PUSA HISPIDA) | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| US3666858A (en) | Utilization of gon-4-ene therapy in treatment of females and in growth stimulation | |
| GB1483650A (en) | Pharmaceutical preparations based on mesterolone | |
| GB1475790A (en) | Contraceptive method and pack | |
| GB1214712A (en) | Contraceptive preparations | |
| GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
| GB1326528A (en) | Method of contraception and compositions used therein | |
| GB1459485A (en) | Medicament pack for the oral treatment with oestrogen | |
| GB1289873A (enExample) | ||
| Asbjorn et al. | Low dose of gestagen as a contraceptive method. A clinical trial | |
| GB1311680A (en) | Contraceptive preparations and method of contraception | |
| Pattillo | Drug and patient matching for safer oral contraception | |
| Wu et al. | Clinical study of a long-acting progestogen contraceptive 3-cyclopentyl propionate of megestrol acetate (progestin no. 1) | |
| Edwards et al. | Estrogens: why harmless as menopausal therapy but hazardous in the" Pill"? | |
| Dhillon et al. | Oral contraceptives and plasma lipids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 433D | Application made for revocation (sect. 33/1949) | ||
| 433B | Case decided by the comptroller ** patent revoked (sect. 33/1949) |